logo
S&P (14 Years Ago) And Fitch (2 Years Ago) Beat Moody's To The Punch

S&P (14 Years Ago) And Fitch (2 Years Ago) Beat Moody's To The Punch

Forbes20-05-2025

A television broadcasts Moody's US credit downgrade news on the floor of the New York Stock Exchange ... More (NYSE) in New York, US, on Monday, May 19, 2025. A renewed wave of dip buying fueled a rebound in stocks from session lows, with traders trying to look past the US downgrade by Moody's Ratings that has sent bond yields climbing and weakened the US dollar. Photographer: Michael Nagle/Bloomberg
While stocks managed to bounce back from early losses the first day after Moody's downgrade of U.S. sovereign credit—bringing it in line with previous actions by Standard & Poor's (2011) and Fitch (2023)—we understand that the decision raises concern about America's fiscal health. But as history has shown, these downgrades have hardly been lasting impediments to long-term equity market gains. For investors with a steady hand and a long-term perspective, the evidence continues to favor staying the course.
The rationale from Moody's echoed familiar concerns: persistent large fiscal deficits, rising entitlement spending and limited political will to rein in debt. They warned of deteriorating fiscal performance relative to other highly rated sovereigns. But they also reaffirmed America's 'exceptional credit strengths,' including the resilience of the U.S. economy and the global primacy of the dollar.
These warnings are not without merit. But similar alarms have sounded before. S&P's 2011 downgrade came during a bitter debt-ceiling impasse. At the time, headlines predicted doom. Yet over the subsequent five years, the S&P 500 nearly doubled. When Fitch followed suit in August 2023, Warren Buffett responded by buying $10 billion in U.S. Treasurys—reiterating his belief in the enduring strength of the American financial system.
JPMorgan Chase CEO Jamie Dimon, too, has long downplayed the significance of such ratings actions, most recently calling Fitch's downgrade 'not that material' and reiterating that 'the U.S. has the best financial system in the world.' He echoed similar sentiments in 2011, when he noted the fundamental strength of the U.S. economy remained intact despite the S&P cut.
Stocks have Soared Since S&P's Downgrade of its U.S. Debt Rating in 2011.
For those who panic at the first sign of turmoil, it's important to remember that volatility is the price of admission for long-term equity returns. Since The Prudent Speculator launched in 1977, the S&P 500 has endured 39 corrections of 10% or more and 40 rallies of similar magnitude. The average gain during these rallies has exceeded 40%, while setbacks have averaged an 18% decline. The secret to success in stocks is not getting scared out of them.
Indeed, the latest consumer sentiment data shows Main Street pessimism nearing levels last seen during the Great Financial Crisis and the COVID-19 collapse. Yet those moments marked historic buying opportunities. The University of Michigan's sentiment index dropped to 50.8 in May, with inflation expectations ticking higher. But such pessimism has often served as a contrarian indicator—when fear peaks, value emerges.
Meanwhile, April's inflation readings came in below expectations, and the Atlanta Fed projects 2.4% real GDP growth for Q2 2025. While that's not gangbuster growth, it defies claims of imminent recession. The labor market remains strong, and interest rates, while higher than recent norms, are still historically accommodative for equities.
Yes, debt matters. But no, these downgrades haven't derailed America's growth story yet. Stocks remain reasonably valued, especially among dividend payers and value-oriented names. We continue to sleep well at night knowing our portfolios emphasize cash-generating businesses with sound fundamentals and generous dividend yields.
The headlines may be grim, but history is generous to those who stay invested. As Mr. Buffett quipped, 'If you're lucky enough to be born in the United States, you've already won the lottery.' That remains true—even in the wake of another downgrade.
For those who like what I have to say in this forum, further market analytics and stock picks can be found in my newsletter, The Prudent Speculator.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why These Market Forecasters Expect Stocks To End the Year at Record Highs
Why These Market Forecasters Expect Stocks To End the Year at Record Highs

Yahoo

time39 minutes ago

  • Yahoo

Why These Market Forecasters Expect Stocks To End the Year at Record Highs

Deutsche Bank analysts led by Chief US Equity & Global Strategist Binky Chadha on Tuesday raised their year-end S&P 500 target to 6,550. That suggests about 10% upside from Tuesday's close. And it would be nearly 7% above the index's record close from earlier this year. Investor positioning, they said, is close to neutral and assumes tariffs will be a slight drag on earnings growth this Wall Street forecasters see stocks closing out 2025 at record highs—despite a shaky start to the year. Deutsche Bank analysts led by Chief US Equity & Global Strategist Binky Chadha on Tuesday raised their year-end S&P 500 target to 6,550, a number suggesting about 10% upside from Tuesday's close. That would be nearly 7% above the index's record close from earlier this year. Investor positioning, they said, is close to neutral and assumes tariffs will be a slight drag on earnings growth this year. 'However, if there is confidence that tariff impacts will be modest and temporary, we expect discretionary investors to look through any slowing in growth and turn overweight in anticipation of a rebound,' they wrote. The analysts expect robust corporate demand to shrink the supply of stock on public markets. They forecast companies will spend $1.1 trillion on stock buybacks this year, thanks to resilient earnings. Deutsche Bank raised its estimate of the S&P 500's aggregate full-year earnings per share to $267 from $240. The firm entered the year forecasting index-level earnings of $282 per share. But it slashed that outlook in mid-April shortly after President Trump paused 'Liberation Day' tariffs for 90 days and lifted rates on Chinese goods to 145% at a minimum. Earnings, they estimated, would suffer from a prohibitively high effective tariff rate and the lingering possibility of a prolonged trade war. The outlook improved last month when the U.S. and China agreed to slash their respective tariff rates while officials negotiated a more comprehensive trade deal. Tensions between the world's two largest economies linger: This weekend each party accusing the other of violating their tentative agreement. Still, the White House's approach to tariff negotiations has some market watchers feeling optimistic. Deutsche Bank's analysts take the White House's decision to pause 'Liberation Day' tariffs just hours after they took effect, 'before the emergence of any legal barriers or economic or political pain,' as a sign that 'if negative impacts of tariffs do materialize, we will get further relents.' As such, Deutsche Bank expects this year's rally to 6,550 to benefit investors who bet on Trump relenting. 'Despite the rhetoric to the contrary, the 2018-2019 dynamic of repeated cycles of escalation and de-escalation predicated on the market looks to be alive and well.' Read the original article on Investopedia

Elon Musk calls Donald Trump-backed tax bill a 'disgusting abomination'
Elon Musk calls Donald Trump-backed tax bill a 'disgusting abomination'

Yahoo

time42 minutes ago

  • Yahoo

Elon Musk calls Donald Trump-backed tax bill a 'disgusting abomination'

Elon Musk has criticised US President Donald Trump's tax and spending bill, calling it "outrageous" and a "disgusting abomination". The bill, which includes multi-trillion-dollar tax breaks, was passed by the House Republicans in May, and has been described by the president as a "big, beautiful bill". The tech billionaire hit out at the tax cuts on his platform X, writing: "This massive, outrageous, pork-filled Congressional spending bill is a disgusting abomination. "Shame on those who voted for it: you know you did wrong. You know it." In American politics, "pork" is a political metaphor used when government spending is allocated to local projects, usually to benefit politicians' constituencies. Musk left the administration abruptly last week after working to cut costs with his team, the newly formed Department of Government Efficiency - known as DOGE - with the ambition of sacking federal workers and cutting red tape. The White House brushed Musk's comments aside, claiming they did not surprise the president. In a press conference on Tuesday, press secretary Karoline Leavitt said that "the president already knows where Elon Musk stood on this bill". She added: "This is one, big, beautiful bill. "And he's sticking to it."

Why Guardant Health Stock Surged Nearly 9% Higher Today
Why Guardant Health Stock Surged Nearly 9% Higher Today

Yahoo

time44 minutes ago

  • Yahoo

Why Guardant Health Stock Surged Nearly 9% Higher Today

The company's Shield multi-cancer detection test won an important designation from a top regulator. This should help bring it to market quicker. 10 stocks we like better than Guardant Health › Precision oncology specialist Guardant Health (NASDAQ: GH) was something of a stock market star on Tuesday. On the back of very positive news in the regulatory sphere, the company's shares jumped almost 9% higher today. This made it quite the outperformer on the exchange, as the bellwether S&P 500 index's gain was a relatively modest 0.6%. This morning before market open, Guardant announced that the U.S. Food and Drug Administration (FDA) had granted the healthcare company's Shield multi-cancer detection (MCD) test its Breakthrough Device designation. This instantly confers a high status on Shield, as the FDA's designation is given only to a small clutch of medical devices that can either diagnose or treat a disease more effectively than other products. In Shield's case, it is quite a versatile diagnostic device that can screen for a wide range of cancers, including colorectal, lung, and ovarian. It is designed to evaluate people 45 years of age or older who are at a typical average risk for cancer. According to Guardant, Shield has 98.6% specificity and 75% sensitivity in detecting certain cancers. In its news release touting the FDA's move, Guardant quoted its co-CEO AmirAli Talasaz as saying that it "shows the promise of the Shield MCD test to detect multiple cancers at an early stage with just a single, routine blood draw." "We look forward to partnering with the agency and other stakeholders to bring this breakthrough to patients quickly," he added. Another big plus of the Breakthrough Device designation is that it's part of an FDA initiative aimed at getting useful medical products to market faster. Talasaz and his team at Guardant might just get their wish with Shield before long. Before you buy stock in Guardant Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Guardant Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,385!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $842,015!* Now, it's worth noting Stock Advisor's total average return is 987% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Guardant Health. The Motley Fool has a disclosure policy. Why Guardant Health Stock Surged Nearly 9% Higher Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store